Nf-at mediates cardiac hypertrophy, methods and reagents...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61K 31/445 (2006.01) A61K 31/70 (2006.01) A61K 38/00 (2006.01) A61K 45/00 (2006.01) A61K 45/08 (2006.01) A61K 48/00 (2006.01) A61P 9/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) C07K 14/57 (2006.01) C07K 16/18 (2006.01) C12N 15/09 (2006.01) C12Q 1/02 (2006.01) C12Q 1/42 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2352599

The invention is a method for treating cardiac hypertrophy, or other preventing other growth of cardiac and vascular tissue, through the use of NF- AT antagonists.

Cette invention se rapporte à un procédé servant à traiter l'hypertrophie cardiaque ou à prévenir toute croissance de tissus cardiaques et vasculaires grâce à l'utilisation d'antagonistes NF-AT.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nf-at mediates cardiac hypertrophy, methods and reagents... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nf-at mediates cardiac hypertrophy, methods and reagents..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nf-at mediates cardiac hypertrophy, methods and reagents... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2081873

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.